Inventor · disambiguated record
Kin Chiu Fong
Also filed as: FONG KIN CHIU
16 granted patents·10 pending applications·79 citations·filing 2007–2025
89Inventor score
Files withGENENTECH INC8NANJING IMMUNOPHAGE BIOTECH CO LTD5MERCK SHARP & DOHME4ARRAY BIOPHARMA INC3XDCEXPLORER SHANGHAI CO LTD2
Top patents by PatentIndex Score
26 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0293US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 0390US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0486US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 0581US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0675US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0773US11807660B2Peptide compound and application thereof, and composition containing peptide compoundXDCEXPLORER SHANGHAI CO LTD·Filed 2022·Granted Nov 7, 2023·0 cites·8 claims
- 0873US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 0970US11981753B2Peptide compound and application thereof, and composition containing peptide compoundSHANGPHARMA INNOVATION INC·Filed 2022·Granted May 14, 2024·0 cites·1 claims
- 1069US2024083912A1Compounds and their uses as mif inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1163US11427615B2Peptide compound and application thereof, and composition containing peptide compoundXDCEXPLORER SHANGHAI CO LTD·Filed 2018·Granted Aug 30, 2022·0 cites·2 claims
- 1263US10100064B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·1 cites·11 claims
- 1362US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1461US2025382283A1Compounds and their uses as cd38 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 1559US2024254113A1Compounds and their uses as cd38 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1654US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 1753US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 1853US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 1953US11884682B2Compounds and their uses as MIF inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Granted Jan 30, 2024·0 cites·14 claims
- 2052US2023038589A1Methods and compositions for targeting Tregs using CCR8 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 2151US9346805B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Granted May 24, 2016·0 cites·59 claims
- 2245US2022144838A1Compounds as Inhibitors of Macrophage Migration Inhibitory FactorFONG KIN CHIU·Filed 2020·Application pending·0 cites
- 2344US2011053931A1Quinoline compounds and methods of useGAUDINO JOHN·Filed 2007·Application pending·0 cites
- 2441US9938281B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·0 cites·18 claims
- 2541US2010256356A1Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 2634US10221178B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Kin Chiu Fong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →